Delporte, C <br/><br/>
Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.  [electronic resource] 

 -  Molecular and cellular endocrinology  Jan 1995 
 - 71-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0303-7207 
<br/><br/><label>Standard No.: </label>10.1016/0303-7207(94)03424-r  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenylyl Cyclases--drug effects<br/>Animals<br/>CHO Cells--drug effects<br/>Calcium--metabolism<br/>Cricetinae<br/>Cyclic AMP--metabolism<br/>Enzyme Activation--drug effects<br/>GTP-Binding Proteins--physiology<br/>Ligands<br/>Neuropeptides--pharmacology<br/>Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I<br/>Receptors, Pituitary Hormone--classification<br/>Recombinant Fusion Proteins--metabolism<br/>Signal Transduction--drug effects<br/>Transfection<br/>Vasoactive Intestinal Peptide--pharmacology